Page-5 of CSIR
CSIR begins clinical trials of two drugs
On May 8, 2020, the Council of Scientific and Industrial Research (CSIR) begins its clinical trials on Favipiravir and Phytopharmaceutical. Highlights Apart from Favipiravir and Phytopharmaceutical, the CSIR is also working on native herbs as biological medicine. The DGCI (Drug ..
Month: Current Affairs - May, 2020
India begins Clinical Trials of AYUSH medicines
On May 7, 2020, the Union Ministry of Health and Family Welfare began clinical trials of AYUSH medicines. The trials are to be conducted on voluntary health workers that are working on the frontline of COVID-19. Highlights The Clinical trials ..
Month: Current Affairs - May, 2020
Kisan Sabha Application developed by CSIR launched
On May 1, 2020, the Council of Scientific and Industrial Research-Central Road Research Institute (CSIR-CRRI) launched Kisan Sabha Application. The application was launched to connect farmers to freight transportation and supply chain. Highlights The application aims in providing timely support ..
Month: Current Affairs - May, 2020
Anti-Leprosy Drug Trials started by CSIR against COVID-19
The Council of Scientific and Industrial Research has started the trials of anti-leprosy drug trials against COVID-19. The drug trial is to be conducted with the help of Mycobacterium MW. Highlights The Mycobacterium MW is a heat killed bacteria. It ..
Month: Current Affairs - April, 2020
Herbal Decongestant Spray developed by CSIR
The Council of Scientific and Industrial Research-National Botanical Research Institute (CSIR-NBRI) has developed herbal decongestant spray. The spray is used to prevent COVID-19 infection and to ease wearing masks. Highlights Wearing mask for a long time creates difficulty in breathing ..
Month: Current Affairs - April, 2020
CSIR: Clinical Trial of “Sepsivac” drug on critically ill COVID-19 patients
On April 22, 2020, the Council of Scientific and Industrial Research announced that it is to go for clinical trials on critically ill COVID-19 patients. Background The Drugs Controller General of India recently approved the trial of “Sepsivac”. The drug ..